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Introduction. One of the main elements for supervising the activity and performance of the University 
Pharmaceutical Center (UPC) is related to economic and financial analysis being a complex process 
involving the interdependence between the preparation, circulation, distribution, provision of 
pharmaceutical services and consumption of pharmaceuticals and parapharmaceuticals. 
Purpose. Systemic study of University Pharmaceutical Center (UPC) dynamics through the analysis of 
economic activity. 
Material and methods. Statistical reports processing according to various indicators using Excel.  
Results.  Recent years, the economic activity of the university center has been affected by a number of 
changes, both legislative and economic. According to the statistical analysis performed, based on the 
management report for the years 2019-2020, there is a significant variation of profit indices in 
economic and financial activity 
The researches and calculations performed by the comparative analysis of the values of the entries 
within the Industrial Forms section, show that the highest commercial discount obtained is attested in 
the first quarter of 2020 (fig.1) in the amount of 94 583.35 lei, with 25% more compared to the first 
quarter of 2019 and a decrease of about 50% in the following quarter of 2020. 
Conclusions. In order to improve the economic situation, sustainable development of the activity by 
increasing the incomes from achievements, avoiding unjustified expenses and optimizing them, 
introducing new pharmaceutical services, etc. will generate the increase and improvement of performance 
indicators. 
























































The same phenomenon registers the commercial discount obtained from the value of outflows for the 
first quarter of 2020 (fig.2) in the amount of 14,269.66 lei, with approx. 52% more than in the same 
quarter of the previous year, continuing with a significant decrease of about 62% in the second quarter 
of 2020. 
Nr. Influencing factors 
1. Cold period of the year; 
2. Location near medical institutions: Republican Clinical 
Hospital, Cardiology Dispensary, etc. 
3. Location of the medical center "Cardioconsult" inside the UPC; 
4. Presence near the Faculty of Pharmacy of SUMP "Nicolae 
Testemitanu" and CEMP "Raisa Pacalo. 
Per pharmacy, however, there is no increase 
in economic indices, conditioned by the 
irrational location of community pharmacies 
in the immediate vicinity of the CFU against 
legal provisions.  Table 1. Factors influencing the increase of the commercial rabate 
Figure 1. Commercial rebate for entries in the period 2019-2020, 
industrial forms section 
Figure 2. Commercial rebate for outings in the period 2019-2020, 
industrial forms section 
The increase of the commercial rebate in this 
quarter, both in terms of input and output, 
was influenced by a series of factors (Table 1). 
 
Within the production section of the CFU, the volume of 
preparation of medicines according to individual prescriptions 
has increased significantly, given the fact that we currently have a 
small number of pharmacies with a production section. However, 
due to the low costs, there is no increase in economic indices. In 
the cold period of the year, the demand rate is the highest, so in 
the first quarter of 2020 the value of entries allowed an increase 
in gross income with 30169.1 lei (32%), with19% more than in 
the first quarter of the previous year ( Figure 3). Respectively, 
this also conditioned a big increase of the commercial rebate 
from the  value of outflows. 
The pharmaceutical company in the production process also bears expenses for packaging, communal 
services, etc., the only source of coverage is the Labor Tax and the cost for purified water, which only 
partially covers the consumption of auxiliary materials used in the preparation of medicinal forms, the 
salary of employees involved in this process and other expenses. 
From fig. 4 it is attested that the value of the maximum 
commercial discount was obtained in the fourth quarter of 
2019, being 257774.83 lei (18%). This value is due to the fact 
that the technological process, in addition to the preparation 
of medicines according to individual prescriptions, also 
includes the preparation of medicinal forms in the form of 
elaborations intended for medical institutions (for inpatients). 



















Figure 4. Commercial rabate for outings  
in the period 2019-2020, production forms section 
1st quarter 
of 2019; 















Figure 3. Commercial rabate for entries  
in the period 2019-2020, production forms section 
